Adcirca
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.adcirca.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Adcirca
ADCIRCA is a prescription medication designed as a phosphodiesterase 5 inhibitor (PDE-5i) for the treatment of pulmonary arterial hypertension (PAH), aimed at improving exercise ability. The product is particularly targeted at patients with NYHA Functional Class II-III symptoms, including those with idiopathic or heritable PAH and PAH associated with connective tissue diseases. Additionally, ADCIRCA provides financial assistance programs for eligible patients to facilitate access to treatment. The medication is not recommended for certain conditions, and patients are advised to consult their healthcare providers regarding their medical history before usage.Explore more
Popular SearchesAdcircaSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adcirca your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Adcirca launches new products
Adcirca, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Adcirca
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Adcirca recently announced quarterly report
Check out if Adcirca is spiking on competitors!
Click to see if Adcirca had a recent Job posting/layoffs
Check if Adcirca has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Adcirca has new funding data
Recommended Actions
Find VP level buyers at Adcirca
Find 3 more new buyers
Compare Similar Companies to Adcirca
Compare insights from companies similar to Adcirca, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Adcirca
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Adcirca is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Adcirca is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Adcirca.
Adcirca Tech Stack
A closer look at the technologies used by Adcirca
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adcirca
Sign Up For FreeTo access detailed company insights
ADCIRCA is a prescription medication designed as a phosphodiesterase 5 inhibitor (PDE-5i) for the treatment of pulmonary arterial hypertension (PAH), aimed at improving exercise ability. The product is particularly targeted at patients with NYHA Functional Class II-III symptoms, including those with idiopathic or heritable PAH and PAH associated wi... Read More
